Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
Generali Asset Management SPA SGR Decreases Stock Holdings in AbbVie Inc. $ABBV
06:18am, Friday, 02'nd Jan 2026
Generali Asset Management SPA SGR lessened its stake in AbbVie Inc. (NYSE: ABBV) by 7.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
Financial Consulate Inc. Takes $731,000 Position in AbbVie Inc. $ABBV
04:27am, Friday, 02'nd Jan 2026
Financial Consulate Inc. bought a new stake in AbbVie Inc. (NYSE: ABBV) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commi
Banque Pictet & Cie SA Has $77.33 Million Stock Position in AbbVie Inc. $ABBV
03:34am, Friday, 02'nd Jan 2026
Banque Pictet and Cie SA grew its stake in shares of AbbVie Inc. (NYSE: ABBV) by 89.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 333
AbbVie: Solid Growth, Some Risks, And An Attractive Setup In 2026
10:24pm, Thursday, 01'st Jan 2026
AbbVie earns a buy rating, with strong 2025 EPS growth driven by Skyrizi and Rinvoq, despite pipeline concerns and a higher P/E. ABBV's valuation remains attractive; a 14.4x FY 2027 multiple is compel
This 4% Bond ETF Matures in 2026, Then Returns Your Principal
07:35am, Thursday, 01'st Jan 2026
Individual corporate bonds typically require $1,000 minimum purchases and leave retail investors stuck with whatever credit quality and maturity dates they can access through their broker. Invesco Bul
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:00am, Wednesday, 31'st Dec 2025
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Best Dividend Aristocrats For January 2026
08:47am, Wednesday, 31'st Dec 2025
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%
Diversified Trust Co Purchases 10,891 Shares of AbbVie Inc. $ABBV
06:16am, Wednesday, 31'st Dec 2025
Diversified Trust Co increased its position in shares of AbbVie Inc. (NYSE: ABBV) by 23.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Calamos Wealth Management LLC Has $3.41 Million Position in AbbVie Inc. $ABBV
05:34am, Wednesday, 31'st Dec 2025
Calamos Wealth Management LLC grew its stake in AbbVie Inc. (NYSE: ABBV) by 74.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (
3 No-Brainer Dividend Stocks to Buy Right Now
03:05pm, Tuesday, 30'th Dec 2025
AbbVie's major drugs, Skyrizi and Rinvoq, are generating lots of sales. Realty Income's diversified portfolio provides plenty of protection and monthly income.
3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains
09:01am, Tuesday, 30'th Dec 2025
Three dividend-paying pharma stocks stand out for steady 2026 gains as innovation, pricing deals and resilient drug demand support returns.
Annex Advisory Services LLC Purchases 2,731 Shares of AbbVie Inc. $ABBV
03:20am, Tuesday, 30'th Dec 2025
Annex Advisory Services LLC increased its position in shares of AbbVie Inc. (NYSE: ABBV) by 4.8% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
Permanent Capital Management LP Makes New Investment in AbbVie Inc. $ABBV
08:22am, Monday, 29'th Dec 2025
Permanent Capital Management LP purchased a new stake in AbbVie Inc. (NYSE: ABBV) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional i
Perigon Wealth Management LLC Purchases 3,905 Shares of AbbVie Inc. $ABBV
07:46am, Monday, 29'th Dec 2025
Perigon Wealth Management LLC lifted its stake in AbbVie Inc. (NYSE: ABBV) by 3.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund o
AbbVie Inc. $ABBV Shares Sold by Sapient Capital LLC
06:28am, Monday, 29'th Dec 2025
Sapient Capital LLC cut its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 3.7% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
